Livzon Pharma (01513.HK) announced on July 30th that it will spend 6.7556 million yuan to repurchase 0.1881 million A-shares on July 30, 2024, with a repurchase price of 35.46-36.08 yuan per share.
丽珠医药(01513.HK)7月30日耗资675.56万元回购18.81万股A股
Livzon Pharma (01513.HK) repurchased 0.1881 million A-shares for a total of 6.7556 million yuan on July 30th.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.